# DESCRIPTION

## FIELD OF INVENTION

- relate to polypeptides and nucleic acid molecules of adeno-associated virus

## BACKGROUND OF THE DISCLOSURE

- introduce gene therapy
- describe adeno-associated virus
- explain AAV genome and capsid proteins
- discuss limitations of recombinant AAV
- motivate need for alternative recombinant AAV

## SUMMARY OF THE DISCLOSURE

- identify adeno-associated virus-derived endogenous viral element
- describe nucleic acid molecules encoding capsid polypeptides
- introduce isolated capsid polypeptide
- define capsid polypeptide sequence identity
- describe regions of capsid polypeptide
- introduce chimeric capsid polypeptide
- define chimeric capsid polypeptide sequence identity
- describe regions of chimeric capsid polypeptide
- introduce recombinant AAV virions
- describe nucleic acid molecules encoding capsid polypeptides
- introduce vectors comprising nucleic acid molecules
- describe host cells comprising rAAV and vectors
- introduce method for introducing heterologous sequence
- describe method for producing chimeric capsid gene
- introduce chimeric capsid genes and libraries
- introduce method for producing rAAV virion

## DETAILED DESCRIPTION

- define technical terms
- incorporate references by reference
- define singular and plural forms
- define "about"
- define "comprise"
- define "vector"
- define "AAV vector"
- define "recombinant AAV"
- define "ITR"
- define "functional" capsid polypeptide
- define "corresponding nucleotides" or "corresponding amino acid residues"
- define "heterologous sequence"
- define "operably-linked"
- define "host cell"
- define "isolated" nucleic acid molecule
- define "subject"
- provide examples of subjects
- clarify non-limiting nature of definitions
- introduce mAAV-EVE1 nucleic acid molecules and polypeptides
- introduce mAAV-EVE1
- describe mAAV-EVE1 structure
- describe mAAV-EVE1 cap gene
- describe mAAV-EVE1 rep gene
- provide polypeptides comprising mAAV-EVE1 capsid polypeptides
- provide VP1 polypeptides
- provide VP2 polypeptides
- provide VP3 polypeptides
- provide fragments of mAAV-EVE1 VP1, VP2 or VP3 proteins
- describe functional fragments
- provide chimeric capsid polypeptides
- describe chimeric capsid polypeptides
- provide nucleic acid molecules encoding capsid polypeptides
- describe nucleic acid molecules encoding capsid polypeptides
- introduce mAAV-EVE1 AAP
- provide AAP polypeptides
- provide fragments of mAAV-EVE1 AAP protein
- describe functional fragments of AAP
- introduce mAAV-EVE1 Rep
- provide Rep polypeptides
- provide fragments of mAAV-EVE1 Rep protein
- describe functional fragments of Rep
- provide nucleic acid molecules encoding Rep polypeptides
- describe nucleic acid molecules encoding Rep polypeptides
- provide promoter operably linked to nucleic acid encoding polypeptide
- describe expression of polypeptide in host cell
- provide functional fragments of Rep
- describe assays for Rep function
- provide examples of Rep fragments
- describe NS2 protein
- provide nucleic acid molecules encoding Rep polypeptides
- describe nucleic acid molecules encoding Rep polypeptides
- conclude description of mAAV-EVE1 polypeptides and nucleic acid molecules

### Vectors

- provide vectors comprising nucleic acid molecule
- describe episomal vectors
- describe integrating vectors
- list exemplary vectors (plasmids, cosmids, AAV, lentiviral, retroviral, adenoviral, herpesviral,
- describe vectors encoding mAAV-EVE1 capsid polypeptide
- describe vectors encoding AAP protein
- describe vectors encoding Rep protein
- describe vectors providing mAAV-EVE1 capsid polypeptides in trans
- describe vectors providing mAAV-EVE1 capsid polypeptides in cis
- describe vectors comprising heterologous sequence
- describe heterologous sequence encoding peptide or polypeptide
- describe heterologous sequence encoding polynucleotide
- describe heterologous sequence for gene therapy
- describe vectors with AAV ITRs
- describe vectors with altered AAV ITRs
- describe vectors with promoters
- describe constitutive promoters
- describe inducible promoters
- describe tissue-specific promoters
- describe vectors with transcriptional enhancers
- describe vectors with translational signals
- describe vectors with transcriptional and translational termination signals
- describe vectors with posttranscriptional regulatory elements
- describe vectors with signal peptide sequences
- describe vectors with regulatory sequences for multiple protein translation

### Recombinant AAV

- provide rAAV virions comprising mAAV-EVE1 capsid polypeptide
- describe production of rAAV using vectors
- describe methods for producing rAAV
- describe packaging cell lines
- describe helper functions for AAV packaging
- describe adenoviral helper genes
- describe purification of rAAV
- describe CsCl gradient purification
- describe solid support purification

### Host Cells

- provide host cells comprising nucleic acid molecule, vector or rAAV virion

### Compositions and Methods

- provide pharmaceutical compositions comprising rAAV and carrier
- describe carriers, diluents, and adjuvants
- describe methods for introducing heterologous sequence into host cell
- describe in vitro, ex vivo, and in vivo methods
- describe therapeutic administration of rAAV
- describe routes of administration

### Capsid Diversification

- introduce capsid diversification techniques
- describe capsid shuffling methods
- motivate DNA family shuffling
- outline DNA family shuffling process
- describe reassembly of gene fragments
- discuss production of chimeric capsid genes
- outline insertion of chimeric genes into vectors
- describe production of rAAV comprising chimeric capsid proteins
- summarize methods for producing chimeric capsid genes and rAAV

### Other Uses

- introduce other uses of mAAV-EVE sequences
- describe detection of other AAV sequences
- motivate use of PCR for detection
- outline design of PCR primers
- describe amplification of target AAV regions
- discuss sequencing of amplicons
- outline method for detecting AAV nucleotide sequences
- describe use of mAAV-EVE sequences for species assignment
- summarize other uses of mAAV-EVE sequences

## EXAMPLES

### Example 1. Identification and Characterization of mAAV-EVE1 Genome and Proteins

- introduce sample acquisition
- describe tissue sample collection
- outline genomic DNA extraction
- detail linker-mediated genome walking
- perform PCR amplification
- describe cloning and sequencing
- extract genomic DNA for locus amplification
- design primers for locus amplification
- perform locus amplification
- describe cloning and sequencing of amplicons
- reconstruct ancestral mAAV-EVE1 sequence
- align multiple sequence alignment
- determine nucleotide substitution model
- construct evolutionary tree
- infer ancestral sequences
- extract ancestral sequences
- identify reading frames
- edit ancestral sequence
- build 3D structure model
- generate VP3 model
- compare VP3 models
- identify VRs
- visualize structures
- assemble mAAV-EVE1 capsid
- generate secondary structure images
- generate capsid surface images
- identify mAAV-EVE1 genome and proteins
- analyze transcription factor binding sites
- compare mAAV-EVE NS1 promoter to AAV2 P5 promoter
- identify putative binding sites for YY1 and MLTF/USF
- describe Rep78 and VP3 proteins
- identify methionine codon and start codon
- characterize Rep protein
- identify conserved protein domains
- analyze BLAST search results
- describe RepN superfamily catalytic domain
- describe parvovirus_NS1 superfamily domain
- identify RCR motifs
- model mAAV-EVE1 Rep nuclease domain
- describe Superfamily 3 helicase domain
- identify Walker motifs
- characterize Capsid protein
- identify phospholipase A2 domain
- analyze VP3 sequence
- build VP3 3D structure model
- describe VP3 monomer structure

### Example 2. Modification of mAAV-EVE Capsid

- modify mAAV-EVE1 capsid protein
- evaluate and change residues
- produce modified mAAV-EVE1 capsid protein

### Example 3. Production of rAAV

- clone mAAV-EVE1 cap gene
- co-transfect plasmids into HEK293T cells
- harvest cells and centrifuge
- treat supernatant with benzonase
- add PEG and centrifuge
- resuspend pellet and incubate
- purify AAV using CsCl gradient
- dialyze and filter rAAV

### Example 4. Assessment of rAAV

- assess rAAV functionality

